skip to main content
Show Results with:

9 results  for Everything in this catalogue

Refined by: author: Saito, Satoru remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

SAT-306-Autotaxin is a valuable biomarker for predicting liver fibrosis in patients with non-alcoholic fatty liver disease

Honda, Yasushi et al.

Journal of hepatology. Volume 70:Number S (2019, April); pp e773-e774

Online access

2
Material Type:
Article
Add to My workspace

Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults

Ogawa, Yuji et al.

Expert opinion on pharmacotherapy. Volume 20:Number 1 (2019); pp 69-82 -- Taylor & Francis

Online access

3
Material Type:
Article
Add to My workspace

Assessment of 10‐year changes in liver stiffness using vibration‐controlled transient elastography in non‐alcoholic fatty liver disease

Nogami, Asako et al.

Hepatology research. Volume 49:Number 8 (2019, August); pp 872-880 -- [Blackwell Publishing]

Online access

4
Material Type:
Article
Add to My workspace

Assessment of 10‐year changes in liver stiffness using vibration‐controlled transient elastography in non‐alcoholic fatty liver disease

Nogami, Asako et al.

Hepatology research. Volume 49:Issue 8 (2019); pp 872-880 -- [Blackwell Publishing]

Online access

5
Material Type:
Article
Add to My workspace

Identification of core gene networks and hub genes associated with progression of non‐alcoholic fatty liver disease by RNA sequencing

Hotta, Kikuko et al.

Hepatology research. Volume 47:Issue 13 (2017); pp 1445-1458 -- [Blackwell Publishing]

Online access

6
Material Type:
Article
Add to My workspace

FRI-312-Increased levels of bile acid in feces plays an important role in pathophysiology of non-alcoholic steatohepatitis

Kessoku, Takaomi et al.

Journal of hepatology. Volume 70:Number S (2019, April); pp e534-

Online access

7
Material Type:
Article
Add to My workspace

Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design

Kessoku, Takaomi et al.

Contemporary clinical trials. Volume 69: (2018, June); pp 40-47 -- Elsevier

Online access

8
Material Type:
Article
Add to My workspace

GS-01-Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease: The LUBIPRONE, doubleblind, randomized, placebo-controlled, phase II study

Kessoku, Takaomi et al.

Journal of hepatology. Volume 70:Number S (2019, April); pp e1-

Online access

9
Material Type:
Article
Add to My workspace

Su1558 Clinical Characteristics of Angiectasia of the Colon: Case-Control Analysis

Sekino, Yusuke et al.

Gastrointestinal endoscopy. Volume 73:Issue 4 (2011, April) Supplement; pp AB304- -- Elsevier Science

Online access

9 results  for Everything in this catalogue

Refine Search Results

Creation date 

From To

Additional Features 

  1. Abstract  (5)
  2. No Abstract  (4)
  3. Refine further open sub menu

Searching Remote Databases, Please Wait